Report Details:
15 Companies Covered
200 Pages
Rising Prevalence of Diseases Set to Expedite the Growth of the Global Clinical Laboratory Services Market Over 2035
Clinical Laboratory Services Market Overview
The global clinical laboratory services market is projected to reach USD 399.19 billion by 2035, growing from USD 262.01 billion in 2024, at a steady CAGR of 3.9% during the forecast period.
The market expansion is primarily driven by the increasing demand for early disease diagnosis, the rise in chronic health conditions, and advancements in diagnostic testing technologies.
Clinical laboratories play an essential role in healthcare systems by providing accurate, timely, and cost-effective diagnostic information critical for patient management and treatment decisions.
The rising prevalence of infectious and lifestyle-related diseases, such as diabetes, cardiovascular disorders, and cancer, has significantly elevated the need for diagnostic screening and pathology services.
Moreover, the growing adoption of digital and automated systems in laboratories, coupled with the shift toward personalized medicine, continues to accelerate market growth.
Increasing awareness about preventive healthcare and the emergence of point-of-care testing are also contributing to the market’s steady progress across both developed and developing economies.
Segment Insights
The clinical laboratory services market is segmented based on type of test, service type, end user, and technology. By type of test, the clinical chemistry segment held the largest market share in 2022 and is anticipated to retain its dominance through 2035.
The growing incidence of chronic conditions requiring blood chemistry, molecular, and genetic testing has supported the segment’s strong performance. Hematology and microbiology segments are also expanding steadily, supported by innovations in automated diagnostic platforms.
Based on service type, the laboratory testing service segment accounted for the largest share in 2022. The increasing number of standalone laboratories and the outsourcing of diagnostic services by hospitals and clinics have boosted this segment’s growth.
By end user, the hospital-based laboratories segment dominated the global market in 2022, benefiting from advanced infrastructure, skilled professionals, and the availability of integrated healthcare systems.
The academic and research institutions segment is projected to grow at a moderate pace during the forecast period, driven by ongoing research in molecular diagnostics and biomarker development.
The technology segment was governed by the automated laboratory technology category. The rising technological infrastructure is propelling the popularity of the category. Point-of-care testing, on the other hand, is likely to gain traction through the forecast period.
Regional Insights
North America led the global clinical laboratory services market in 2022, accounting for 45% of the overall share. The region’s growth is fueled by the high prevalence of chronic diseases, well-established healthcare infrastructure, and significant investments in diagnostic technology innovation.
The United States remains the largest market within the region, supported by advanced clinical networks and the adoption of automated testing platforms.
Europe captured 30% of the global market share in 2022, driven by the increasing demand for preventive diagnostics and strong government support for healthcare digitalization.
Countries such as Germany, the UK, and France are key contributors to regional growth, emphasizing improved access to early diagnostic services and precision medicine. The Asia-Pacific (APAC) region held a 20% market share in 2022 and is projected to record the fastest growth over the forecast period.
The regional expansion is attributed to improving healthcare infrastructure, increasing healthcare expenditure, and the rising prevalence of infectious diseases in emerging economies such as India, China, and Indonesia.
Moreover, the growing adoption of advanced diagnostic technologies and the expansion of private laboratory chains are reinforcing the region’s growth prospects.
The Middle East and Africa (MEA) accounted for approximately 5% of the global share in 2022. While still emerging, the region is witnessing increased investment in healthcare diagnostics and the establishment of modern laboratories in urban centers, particularly in the UAE and Saudi Arabia.
Key Players
Prominent companies operating in the global clinical laboratory services market include Laboratory Corporation of America Holdings (US), Quest Diagnostics Incorporated (US), Sonic Healthcare Limited (Australia), Eurofins Scientific SE (Luxembourg), Synlab International GmbH (Germany), and Unilabs (Switzerland).
These players are focusing on strategic collaborations, acquisitions, and geographic expansions to strengthen their global footprint. Technological advancements in molecular diagnostics, automation, and digital pathology are central to their competitive strategies.
Continuous investment in laboratory automation and AI-based diagnostic solutions is expected to enhance testing efficiency, accuracy, and turnaround times.
Industry Developments
- In February 2025, Quest Diagnostics partnered with Pfizer to advance companion diagnostic testing for oncology applications, expanding its molecular testing portfolio.
- In August 2024, Eurofins Scientific launched a new comprehensive genetic testing panel designed for early detection of hereditary cardiovascular diseases.
- In May 2023, Sonic Healthcare completed the acquisition of a regional diagnostic network in Japan, strengthening its presence in the Asia-Pacific market.
These developments underscore the industry’s strategic focus on innovation, partnerships, and global expansion to improve diagnostic precision and accessibility.
Key Findings
- The global clinical laboratory services market will grow from USD 262.01 billion in 2024 to USD 399.19 billion by 2035, at a CAGR of 3.9%.
- North America dominated the market with a 45% share, followed by Europe (30%), Asia-Pacific (20%), and MEA (5%).
- Laboratory testing services remained the largest service types, supported by outsourcing trends and growing diagnostic demand.
- Automation, digital pathology, and AI integration are key technological drivers shaping the market’s future.
- Strategic partnerships and acquisitions are accelerating innovation and expanding the global reach of leading players.
